Orphan Drug Designation Granted to OVATION's Clobazam for the Adjunctive Treatment of a Severe Form of Childhood ... (Centre Daily Times)
OVATION Pharmaceuticals, Inc. was granted special status by the U.S. Food and Drug Administration (FDA) for clobazam as an adjunctive treatment for Lennox-Gastaut syndrome (LGS), one of the most severe forms of childhood epilepsy that frequently persists into adulthood. The FDA grants orphan drug designation to products that are intended to treat rare or "orphaned" diseases or conditions such as ...

Luminex Corporation Receives U.S. Food and Drug Administration Clearance for xTAG(TM) Respiratory Viral Panel (Centre Daily Times)
Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its xTAG(TM) Respiratory Viral Panel (RVP). xTAG RVP is the first FDA-cleared assay to simultaneously detect and identify 12 viruses and viral subtypes that together are responsible for more than 85 percent ...

Luminex Corporation Receives U.S. Food and Drug Administration Clearance for xTAG(TM) Respiratory Viral Panel (Business Wire via Yahoo! Finance)
AUSTIN, Texas----Luminex Corporation , the worldwide leader in multiplexed solutions, today announced that it has received 510 clearance from the U.S. Food and Drug Administration for its xTAG Respiratory Viral Panel . xTAG RVP is the first FDA-cleared assay to simultaneously detect and identify 12 viruses and viral subtypes that together are responsible for more than 85 percent of respiratory ...